Zena N Willsmore Selected Research

Complementarity Determining Regions (Complementarity Determining Region)

1/2023

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zena N Willsmore Research Topics

Disease

3	Melanoma (Melanoma, Malignant) 01/2023 - 01/2020
3	Neoplasms (Cancer) 01/2023 - 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Hyperplasia 12/2021

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 01/2023 - 01/2020
2	pembrolizumabIBA 01/2022 - 01/2021
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2023
1	AntigensIBA 01/2023
1	AutoantigensIBA 01/2023
1	Death Domain ReceptorsIBA 01/2021
1	IpilimumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	cyclopropapyrroloindoleIBA 01/2020

Therapy/Procedure

2	Immunotherapy 01/2021 - 01/2020
1	Therapeutics 01/2022